TissueMatcher is a private data driven bio-tech company based in Oosterbeek (near city of Arnhem), the Netherlands and Kamakura-City, Japan. Our company is dedicated to make it easier to find, match, share and store stem cells and medical data.
Dr. Hugo Sondermeijer, CEO of TissueMatcher, Cees Hupkes, COO (i-Cruit B.V.) and Thijs Vermeer, CTO (Product Owner Digitalisering Xebia and Alliander) founded TissueMatcher. The TissueMatcher development program is based on improving and speeding up the exchange of medical data between donors and recipients, as well as for personal use. The availability of HLA profiles will be increased in a decentralized way. For this purpose, Tissuematcher is developing a platform for its users on the Ethereum blockchain to establish a global, interconnected HLA database network with an AI matching service.
Members of the platform will be able to match their HLA information using our unique ledger-based platform. HLA profile exchange and stem cell storage are safeguarded by and linked to personal NFTs. Our platform will assist biotech and therapeutic companies in attracting specific groups for therapeutic stem cell research, both observational and clinical.
Our leadership philosophy is built on the principles of freedom and trust, distributed decision-making, and radical transparency. We believe in creating a network of teams that work together to achieve our goals and in developing the talents and mastery of each future team member. Our leadership is supportive and encourages experimentation and adaptation. We foster communities of like-minded people, customers, and partners, working together to build a collective will that drives the company forward. We believe that by fostering transparency and trust, we can create a vibrant platform where everyone can benefit from the latest advancements in stem cell therapy and research.
The leadership is well-known for developing innovative e-commerce platforms, online recruitment solutions, digitalization, and academic research. The team is made up of strong professional leaders who are skilled at execution and problem-solving, strategic partnership development, and innovation. All share a clear vision for the future of stem cell therapy and autonomous platform-driven economies.